Fall 2007

Cancer survivors may experience chronic pain long after treatment, but support and information resources are available to help.

Pain clinics combine a variety of therapeutic approaches to effectively help patients and lower health care costs, but don’t have much support from insurance companies.

Questions about the safety of approved drugs has the FDA poised to reform.

Strategies for diagnosing and treating sarcomas shift to a more patient-specific approach.

Are breast cancer rates dropping because of the HRT decline, or are other factors at work?

Helpful tips for finding a certified mammography center near you.

Predictive markers help oncologists match patients with the most effective treatments.

The old and the new in myeloma therapy give patients more options.

As more cancer drugs become self-administered, why aren’t patients taking their medicine?

Registries reveal links for cancer that runs in the family.

Struggling with the sorrow of anticipatory grief.

Readers respond to articles on never-smokers get lung cancer too, cancer & robots, and proton beam therapy, and finding Cure magazine.

Researchers and advocates offer explanations for why patients may not take their medicine as directed and suggestions on what can help.

Eleven tips to help cancer patients remember to take their medicine as directed.

Survivors participating in a family registry, and helping with cancer research, should weigh all emotional and logistical options.

Caregivers can encourage the patient to take an active role in decision making at the end of life with these six suggestions.

New regulations address what's in a supplement but not if it's safe or effective.

How a paddle replaced anger with joy.

Maintaining a balance between access to new drugs and protecting consumers.

Since the Food and Drug Administration has come under scrutiny to ensure drug safety, CURE asks what it could mean for cancer drug approvals and patients.

Patients are encouraged to report an adverse drug reaction to their doctor and the FDA.

Fewer sarcoma patients are facing limb amputation with limb-salvaging surgery, but for survivors like Joshua Isaac, physical and emotional rehabilitation can help.

Some cancer therapies can increase the risk of secondary cancers such as sarcoma, especially for childhood cancer survivors.

The Women’s Health Initiative study suggested that HRT increased the risk of breast cancer, blood clots, and stroke, but it also may lower the risk of colorectal cancer and fractures.

Breast cancer survivors look for alternatives to HRT to quell their hot flashes, including antidepressants, antiseizure medications, and integrative therapies.

The European Union monitors drug safety in a slightly different fashion than the United States’s Food and Drug Administration.

While sarcomas can be divided into soft-tissue or bone sarcomas, there are about 600 different types of sarcomas patients can be diagnosed with.

Five years after the results of the Women’s Health Initiative were announced linking combined hormone replacement therapy to an increased risk of breast cancer, research continues on its benefits and risks.

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends survival in patients with MDS.

A number of diagnostic, prognostic, or predictive tests can help determine the optimal course of treatment by using predictive markers from the patient’s or tumor’s genetic information.